Related Experiment Video
Updated: Dec 18, 2025

06:33
Production of Human CRISPR-Engineered CAR-T Cells
Published on: March 15, 2021
14.1K
Publisher Correction: Safety and feasibility of CRISPR-edited T cells in patients with refractory non-small-cell lung
You Lu1, Jianxin Xue2, Tao Deng3
1Department of Thoracic Oncology, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China. radyoulu@hotmail.com.
Nature Medicine
|June 20, 2020
Abstract:
An amendment to this paper has been published and can be accessed via a link at the top of the paper.

